A 26-year-old African American female with a history of genital herpes developed hematochezia 6 weeks prior to hospital admission. She was seen at an urgent care center and was prescribed a 1-week course of oral antibiotics. The patient continued to have hematochezia for which she was scheduled to have a colonoscopy as an outpatient. Her hematochezia worsened over the next 2 weeks and she was admitted to an outside hospital where she was managed with a presumed flare of ulcerative colitis (UC) based on clinical diagnosis. The patient was treated with oral steroids and intravenous antibiotics and discharged on a tapering course of steroids for 1 week. During the hospitalization, her platelet count was 236×10^3^/mm^3^.

She experienced partial improvement in her symptoms with steroids use, but shortly after stopping steroids her symptoms worsened. She presented to our hospital emergency department with 2 days of 8--9 bloody bowel movements per day, mild left-lower quadrant abdominal pain, no fever or chills but reported a 20 pound weight loss. On admission, her white cell count was 10,370/mm^3^, hemoglobin of 11.4 g/dL, and platelet count was 76×10^3^/mm^3^. Intravenous methylprednisolone was administered. Her medications were reviewed for possible thrombocytopenia and there was no reported history of alcohol use. HIV and *H. pylori* serology and blood cultures were negative. Colonoscopy showed pan colitis with histopathology consistent with UC without any viral inclusions.

On day 5 of hospitalization, her platelet count decreased to 5×10^3^/mm^3^, her frequency of bloody bowel movement increased, and she became febrile and tachycardic. The patient was started on intravenous ciprofloxacin plus metronidazole and intravenous steroids were continued. The peripheral smear showed few large size platelets and the patient did not have splenomegaly. These results suggested the possibility of immune mediated peripheral destruction of platelets. Intravenous immunoglobulin (IVIGg) was administered and one unit of platelets transfused. On days 6 and 7, platelet counts improved to 24×10^3^/mm^3^ and 36×10^3^/mm^3^, respectively, but the patient continued having bloody bowel movements. Positive platelet-associated antibodies confirmed diagnosis of immune thrombocytopenic purpura (ITP). Because of the lack of response to steroids, Infliximab infusion 5 mg/kg was administered on day 7. On days 8 and 9, frequency of bloody stool decreased significantly and platelet count continued to improve, 94×10^3^/mm^3^ on day 9. At that point, the patient was discharged on a tapering dose of steroids and scheduled Infliximab infusion. On outpatient follow-up 10 days after discharge, her platelet count was normal at 151×10^3^/mm^3^ and she was free of hematochezia.

Systematic review {#S0002}
=================

Search and data compilation {#S0002-S20001}
---------------------------

A comprehensive search of two major databases of biomedical publications was performed during the last week of August 2013. No age or language restrictions were applied. A summary of our search strategy is described in the [Appendix](#APP0001){ref-type="app"}. Titles and abstracts were reviewed to identify cases. The references of eligible articles were hand searched to elicit additional cases. All of the adult and pediatric cases reports and series reporting UC associated with ITP were included. Data points were extracted based on the best information reported.

Results {#S0003}
=======

Cases of ITP associated with UC were first reported in 1963 ([@CIT0001]). Since then, a total of 40 cases (including the above-mentioned case) were identified, seven of them being of pediatric age group. [Table 1](#T0001){ref-type="table"} summarizes patient demographics and management of UC and associated ITP. Fifty six percent of cases were male and the median age of presentation was 27 years (interquartile range 14--42 years). Median age of presentation was higher in females (41 vs. 22 years) but the difference was not statistically significant (p =0.0718). As shown in [Table 1](#T0001){ref-type="table"}, 52% of patients were white, 45% were Asian (mostly of Japanese origin). The current report documents the first case in an African American patient.

###### 

Summary demographics and treatment in reported cases

  Author              Year   Age         Gender   Race    Medical treatment UC            Additional medical treatment for ITP   Surgical treatment       Comments
  ------------------- ------ ----------- -------- ------- ------------------------------- -------------------------------------- ------------------------ ----------------------------------------------------------------------------------------
  Edwards             1964   Adult       --       --      --                              --                                     --                       3-cases
  Kocoshis            1979   Pediatric   --       --      --                              --                                     --                       --
  Hautefeuille        1985   20          M        White   Steroid                         IVIGg                                  Splenectomy, colectomy   Good response to surgical intervention
  Dooley              1986   63          M        White   Sulfa, steroid                  --                                     Splenectomy              Partial response to steroids, complete resolution of ITP with splenectomy
  Gupta               1986   42          M        White   Sulfa, steroid                  --                                     Splenectomy              No response to steroid
  Mori                1987   50          F        Asian   --                              Steroid                                --                       Platelet count maintained on 1 mg daily betamethasone
  Jimbo               1992   24          M        Asian   Sulfa, steroid                  --                                     --                       No recurrence with subsequent flare
  Adachi              1994   49          F        Asian   Sulfa, steroid                  --                                     Splenectomy              --
  Fernandez-Miranda   1994   22          F        White   5-ASA, steroid                  --                                     Splenectomy              Partial response to steroids, complete resolution of ITP with splenectomy
  Obata               1994   13          F        Asian   Steroid                         --                                     --                       --
  Kim                 1995   41          M        White   5-ASA, steroid                  IVIGg                                  Splenectomy              Good response to medical treatment but underwent splenectomy
  McCulley            1996   21          F        White   5-ASA, steroid, metronidazole   --                                     --                       --
  Yoshida             1996   27          M        White   5-ASA, steroid                  IVIGg                                  --                       Chronic thrombocytopenia despite multiple courses of steroids
  Yoshida             1996   65          F        White   5-ASA, steroid                  IVIGg                                  --                       --
  Yoshida             1996   42          F        White   5-ASA, steroid                  --                                     Splenectomy              --
  Nagata              1997   19          M        Asian   Steroid                         --                                     --                       --
  Zlatanic            1997   18          M        White   5-ASA, steroid, 6-MP            6-MP and IVIGg                         --                       --
  Bauer               1999   24          F        White   5-ASA                           IVIGg                                  Splenectomy, Colectomy   Resistant to IVIGg and splenectomy but responded to colectomy
  Kodaira             1999   23          M        Asian   Sulfa, steroid                  --                                     Splenectomy              Responded to steroids but reoccurred for which splenectomy was performed
  Chetri              1999   42          M        Asian   5-ASA, steroid                  azathioprine                           --                       --
  --                  1999   52          F        Asian   5-ASA, steroid, azathioprine    --                                     Splenectomy              ITP preceded UC by 18 years
  Higuchi             2001   9           M        --      Sulfa                           Anti-D antibodies                      --                       --
  --                  2001   17          M        --      Steroid                         IVIGg                                  --                       --
  --                  2001   5           F        --      5-ASA, steroid                  Anti-D antibodies, IVIGg               --                       Responded will after starting 5-ASA
  --                  2001   14          M        --      5-ASA, steroid, 6-MP            IVIGg                                  Colectomy                Recurrent ITP despite colectomy
  Kathula             2001   28          F        --      Steroid                         IVIGg                                  Colectomy, splenectomy   Transient response to IVIGg and splenectomy, complete resolution of ITP with colectomy
  Miner               2001   63          F        --      5-ASA, steroid, metronidazole   --                                     Splenectomy              Splenectomy for recurrence of ITP with steroid tapper
  Mizuta              2003   19          M        Asian   5-ASA, steroid                  --                                     Colectomy                --
  --                  2003   51          F        Asian   5-ASA, steroid                  --                                     --                       Patient expired from intracranial hemorrhage
  Puebla-Maestu       2003   41          F        White   5-ASA, steroid                  Cyclosporine, azathioprine             Colectomy Splenectomy    Not responded well to medical treatment
  Varderili           2003   20          M        White   Steroid                         --                                     Colectomy                Partial response to steroids, complete resolution of ITP with colectomy
  Hisada              2006   36          M        Asian   Steroid                         IVIGg                                  Colectomy                Good response to IVIGg and complete response following colectomy
  Kawakubo            2008   53          M        Asian   Steroid                         --                                     --                       ITP preceded UC
  Yong                2008   14          M        White   --                              IVIGg                                  --                       ITP after colectomy
  Shao                2009   19          M        Asian   5-ASA, steroid                  --                                     --                       --
  Mares               2011   32          M        White   Steroid, Infliximab             IVIGg                                  --                       --
  Etou                2013   41          F        Asian   No exacerbation of UC           --                                     --                       ITP resolved on eradication of *H. pylori*
  Chandra             2013   26          F        Black   Steroid, Infliximab             IVIGg                                  --                       Patient did not tolerate 5-ASA

ITP: immune thrombocytopenic purpura; IVIGg: intravenous immunoglobulin G; Sulfa: sulfasalazine; UC: ulcerative colitis.

In the majority of cases, ITP resolved with treatment of UC flare. IVIGg or anti-D antibodies were used in 15 cases; response was adequate and lasting in 11 of them. Amongst the remaining four patients, one responded dramatically to 5-ASA; in two cases, ITP was resistant to both IVIGg and splenectomy and required a colectomy; and in one case, colectomy and splenectomy were performed together, which improved the ITP. Ten patients underwent a colectomy; one of them had a colectomy some years prior to the development of ITP ([@CIT0002]). Of the remaining nine cases, eight responded well but one patient continued to have recurrent ITP despite colectomy ([@CIT0003]). In one case, ITP resolved with *H. pylori* eradication ([@CIT0004]).

Discussion {#S0004}
==========

The development of ITP adds complexity in the clinical course of UC flare as the number of bloody bowel movements is one of the important criteria to assess disease severity. Since 1965, a total of 40 cases reported association of ITP with UC. Rarity of occurrence limits methodologically sound studies to establish causal relationship between the two disorders. In disease epidemiology, Sir Austin Bradford Hill proposed criteria for causation, also knows has Hill\'s criteria for causation ([@CIT0005]). Results of this systematic review elicit multiple interesting observations to generate a hypothesis of causal relationships between UC and ITP. 1) In most cases, UC preceded ITP, which demonstrates a temporal relationship between UC (exposure) and ITP (effect). Only three cases have been reported where ITP preceded UC ([@CIT0006], [@CIT0007]). In two of the cases, ITP preceded UC by just 18 months. This could be a result of delay in diagnosis or subclinical disease, which is not uncommon in UC. In another case, ITP preceded UC by 18 years, which appears to be a result of random concurrence of the two disorders. 2) Platelet count was lowest during the flare of UC, demonstrating a biological gradient. 3) In most cases, treatment of UC resolved ITP, analogous to the removal of exposure leading to reversal of effect. Biological plausibility in ITP development in patients with UC is hypothesized to be due to antigenic mimicry between platelet surface antigen and luminal antigens, including bacterial surface antigen. Increased exposure to luminal antigens is thought to be the result of mucosal injury. This is also postulated for the association of ITP with Crohn\'s disease ([@CIT0008]).

The results of our systematic review suggest that peak age for this association is in the third decade of life with a trend towards earlier occurrence in males. Cases have been reported in both pediatrics and adults above 60 years of age. About half of the cases were reported in the Japanese population. We report the first case in the African American population. In the management of this coexistence, treatment of UC is the corner stone. In severe cases of thrombocytopenia, IVIGs or Anti-D antibodies in combination with 5-ASA and/or steroids are effective in most cases. These patients should also be screened for *H. pylori*. The infection needs to be eradicated if presented. Refractory cases respond to colectomy and splenectomy but are rarely necessary ([@CIT0004]). We are reporting a second case where a colectomy was avoided by using anti-tumor necrosis factor therapy ([@CIT0009]).

In conclusion, ITP appears to be an extraintestinal manifestation of UC. The proposed pathogenesis is antigenic mimicry between luminal antigen and platelet surface antigen. Treatment of underlying UC flare is the cornerstone in managing the condition and in severe cases of ITP, IVIGs is effective. Though colectomy has been proposed as a definitive treatment option, the use of biological agents is an acceptable alternative in a steroid-resistant case of UC associated with ITP.
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Database: Embase \<1988 to 2013 Week 34\>, Ovid MEDLINE(R) \<1946 to August Week 2 2013\>

Search Strategy:

1\. Ulcerative colitis.ab. or Ulcerative colitis.ti. or Ulcerative colitis.kw. or Ulcerative colitis.kf. (54,832)

2\. Autoimmune thrombocytopenic purpura.ab. or autoimmune thrombocytopenic purpura.ti. or autoimmune thrombocytopenic purpura.kw. or autoimmune thrombocytopenic purpura.kf. (810)

3\. Idiopathic thrombocytopenic purpura.ab. or idiopathic thrombocytopenic purpura.ti. or idiopathic thrombocytopenic purpura.kw. or idiopathic thrombocytopenic purpura.kf. (7,469)

4\. ITP.ab. or ITP.ti. or ITP.kw. or ITP.kf. (10,614)

5\. 2 or 3 or 4 (15,035)

6\. 1 and 5 (61)

7\. Remove duplicates from 6 (37)
